The FDA has indicated there may be an association between a weight loss drug and liver disease. In its over-the-counter form, it’s sold as Alli. In prescription strength, its Xenical. Either way, the primary ingredient is Orlistat.
The story broke on the AP. The source of the news is the FDA “early communication about an ongoing safety review,” found here.
With the recent focus on the risks of common medications (Tylenol) as well as the Michael Jackson homicide case, it will be interesting to see if the name “Alli” appears in lawyer ads soon.